PMN
insider transactionsProMIS Neurosciences Inc. — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
Net shares · 90d
+4.0K
4.0K buy · 0 sell
Net value · 90d
$45.3K
$45.3K in · $0 out
Sentiment · 90d
Net buying
100% buying · 0% selling
Open-market trades · 90d
1
4.0K buy · 0 sell
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
All transactions
-
Grant·A
Director
$0
11.0K sh
Own New
-
Grant·A
Director
$0
5.5K sh
Own New
-
Grant·A
Director
$0
11.0K sh
Own New
-
Grant·A
Director
$0
5.5K sh
Own New
-
Grant·A
Neil K Warma KEY
Chief Executive Officer
$0
160.0K sh
Own New
-
Grant·A
Director
$0
11.0K sh
Own New
-
Grant·A
Director
$0
5.5K sh
Own New
-
Grant·A
Principal Accounting Officer
$0
18.2K sh
Own New
-
Grant·A
Director
$0
11.0K sh
Own New
-
Grant·A
Director
$0
5.5K sh
Own New
-
Grant·A
Chief Development Officer
$0
50.0K sh
Own New
-
Grant·A
Chief Scientific Officer
$0
50.0K sh
Own New
-
Grant·A
Director
$0
11.0K sh
Own New
-
Grant·A
Director
$0
5.5K sh
Own New
-
Buy·P
Director
$45.3K
4.0K sh · $11.33
Own +613%
| Date▾ | Insider | Type | Shares | Value |
|---|---|---|---|---|
| May 20, 2026 | William W Wyman | Grant A | 11.0K | $0 |
| May 20, 2026 | William W Wyman | Grant A | 5.5K | $0 |
| May 20, 2026 | Eugene Williams | Grant A | 11.0K | $0 |
| May 20, 2026 | Eugene Williams | Grant A | 5.5K | $0 |
| May 20, 2026 | Neil K Warma KEY | Grant A | 160.0K | $0 |
| May 20, 2026 | Madge K. Shafmaster | Grant A | 11.0K | $0 |
| May 20, 2026 | Madge K. Shafmaster | Grant A | 5.5K | $0 |
| May 20, 2026 | Max A. Milbury | Grant A | 18.2K | $0 |
| May 20, 2026 | Josh Mandel-Brehm | Grant A | 11.0K | $0 |
| May 20, 2026 | Josh Mandel-Brehm | Grant A | 5.5K | $0 |
| May 20, 2026 | Johanne Kaplan | Grant A | 50.0K | $0 |
| May 20, 2026 | Neil Cashman | Grant A | 50.0K | $0 |
| May 20, 2026 | Slanix Paul Alex | Grant A | 11.0K | $0 |
| May 20, 2026 | Slanix Paul Alex | Grant A | 5.5K | $0 |
| Apr 22, 2026 | Patrick D. Kirwin | Buy P | 4.0K | $45.3K |
About PMN insider trading
This page tracks insider transactions for ProMIS Neurosciences Inc. (PMN) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.